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Maurocalcine (MCa) is a 33-amino acid residue peptide toxin initially isolated from the scorpion Scorpio maurus maurus. Its structural and
functional features make it resembling many Cell Penetrating Peptides. In particular, MCa exhibits a characteristic positively charged face that
may interact with membrane lipids. External application of MCa is known to produce Ca2+-release from intracellular stores within seconds. MCa
binds directly to the skeletal muscle isoform of the ryanodine receptor, an intracellular channel target of the endoplasmic reticulum, and induces
long-lasting channel openings in a mode of smaller conductance. The binding sites for MCa have been mapped within the cytoplasmic domain of
the ryanodine receptor. In this manuscript, we further investigated how MCa proceeds to cross biological membranes in order to reach its target. A
biotinylated derivative of MCa (MCab) was chemically synthesized, coupled to a fluorescent streptavidin indicator (Cy3 or Cy5) and the cell
penetration of the entire complex followed by confocal microscopy and FACS analysis. The data provide evidence that MCa allows the
penetration of the macro proteic complex and therefore may be used as a vector for the delivery of proteins in the cytoplasm as well as in the
nucleus. Using both FACS and confocal analysis, we show that the cell penetration of the fluorescent complex is observed at concentrations as low
as 10 nM, is sensitive to membrane potential and is partly inhibited by heparin. We also show that MCa interacts with the disialoganglioside GD3,
the most abundant charged lipid in natural membranes. Despite its action on ryanodine receptor, MCa showed no sign of cell toxicity on HEK293
cells suggesting that it may have a wider application range. These data indicate that MCa may cross the plasma membrane directly by cell
translocation and has a promising future as a carrier of various drugs and agents of therapeutic, diagnostic and technological value.
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Maurocalcine (MCa) is a 33 amino acid residue peptide that
was initially isolated from the venom of the chactid scorpion
Scorpio maurus maurus [1] (Fig. 1A). Since then, it has been
chemically synthesized without any loss in pharmacological
activity or structural alteration [2]. The peptide is cross-linked
by three disulfide bridges according to the pattern: Cys3–Cys17,
Fig. 1. (A) Scorpio maurus palmatus, (B) amino acid sequence of MCa and (C) presentation of the basic face of MCa. (A) Image of the scorpion Scorpio maurus
palmatus from which MCa has been isolated. (B) Sequence alignment of four analogous toxins, MCa, imperatoxin A, opicalcine 1 and opicalcine 2. The two first
peptides are known to be active on the ryanodine receptor. Opicalcine and imperatoxin A are from different scorpion venoms. All four toxins have the same number of
positively charged amino acid residues. (C) 3-D structure of MCa drawn by theWebLab ViewerPro software and surface colored according to the electrostatic potential
(blue and red represent positively and negatively charged amino acid residues, respectively). The basic face (right panel) depicts all positively charged residues of MCa
(Gly1, Lys8, Lys11, Lys14, Lys19, Lys20, Lys22 and Lys30). The hydrophobic face illustrates the lack of positively charged amino acid residues on the opposite side of the
molecule. The peptide backbone is depicted as a yellow ribbon, whereas only the lateral chains of positively charged amino acid residues are indicated with scaled balls
and sticks.
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determined in solution by 1H-NMR [3], shows an inhibitor
cystine knot motif [4] and three β-strands running from amino
acid residues 9–11 (strand 1), 20–23 (strand 2) and 30–33
(strand 3), respectively. The β-strands 2 and 3 form an
antiparallel sheet. MCa is a highly basic peptide since 12 out
of 33 residues are positively charged, including the amino
terminal Gly residue, seven Lys residues and four Arg residues
(Fig. 1B). In contrast, MCa contains only four negatively
charged residues, meaning that the global net charge is positive.
A representation of the electrostatic surface potential of MCa
demonstrates that MCa presents a basic face in which the first
Gly residue and all Lys residues are involved (Fig. 1C, left
panel). Interestingly, none of the four Arg residues are involved
in this basic face. The rest of the molecule is mainly
hydrophobic (Fig. 1C, right panel), meaning that MCa is a
strongly polarized molecule and possesses an important dipole
moment. Three relative peptides have been isolated or cloned
from the venoms of different scorpions: imperatoxin A [5], from
the scorpion Pandinus imperator, that shares 82% sequence
identity with MCa, and both opicalcine 1 and 2 [6], from the
scorpion Opistophthalmus carinatus, that show higher 91% and
88% sequence identities, respectively (Fig. 1B). In these threeanalogues, amino acid substitutions did not alter the net global
charge of the peptides.
MCa and imperatoxin A have initially triggered interest for
two reasons. First, they are potent activators of the ryanodine
receptor (RyR), a calcium channel responsible for the release
of calcium from intracellular stores [5,7]. Indeed, both toxins
bind with nanomolar affinity onto the skeletal muscle isoform
of the RyR inducing an increase in opening probability and
the appearance of long-lasting openings of the channel at a
sub-maximal conductance state. These effects are responsible
for the property of MCa to induce calcium release from the
sarcoplasmic reticulum (SR) [2,8,9]. Moderate effects of
imperatoxin A have been reported on the cardiac (type 2) and
brain (type 3) RyR isoforms as well [10,11]. Interestingly,
application of MCa in the extracellular medium of cultured
myocytes triggers, within seconds, a transient calcium release
from the SR intracellular store [7]. Second, both toxins
present some sequence homology with a cytoplasmic
sequence (termed domain A) of the pore-forming subunit of
the dihydropyridine (DHP)-sensitive voltage-gated calcium
channel of skeletal muscle (DHP receptor, DHPR) [7,12].
This homology is located in a DHPR region known to be
important for the mechanical coupling between the DHPR
310 S. Boisseau et al. / Biochimica et Biophysica Acta 1758 (2006) 308–319and RyR, a physiologically process required for SR calcium
release and therefore muscle contraction. Besides this
sequence homology, it has been proposed that the β-sheet
structure of the MCa and imperatoxin could mimic the helical
structure of domain A [13]. In addition, a peptide of domain
A, MCa and imperatoxin A were all shown to induce similar
modifications in RyR channel properties [2,8,9]. Peptide A
was found to block at least some effects of MCa [8] or
imperatoxin A [14]. Finally, we recently demonstrated that
MCa and peptide A share common binding sites on RyR [15].
As such, MCa and its related analogues are interesting
peptide tools for dissecting the molecular events that lead to
muscle contraction [16]. Fig. 2 summarizes the major aspects
of these findings.
Given the location of the site of pharmacological action of
MCa and its analogues, combined with the rapid effect of
MCa on cultured myocytes Ca2+ homeostasis upon external
application, these peptides ought to efficiently cross the
plasma membrane through a process faster than endocytosis.
Therefore, these peptides now become interesting for a third
reason: they may be derived for technological purposes in
order to favor the membrane translocation of non-permeable
molecules or nano-compounds. Proof that MCa translocates
across the plasma membrane was recently provided by using
a biotinylated derivative of MCa (MCab) that was coupled to
a fluorescent derivative of streptavidine (Strep) [17]. Indeed,
we showed that the MCab–Strep complex efficiently
penetrates into various cell types without requiring metabolic
energy or endocytosis. This penetration was rapid and reached
saturation within 20 min for an external MCa concentration of
100 nM. MCa appears to share several traits with other cell
penetrating peptides (CPPs) such as the HIV-encoded
transactivator of transcription (Tat) [18], the insect transcrip-
tion factor Antennapedia (Antp, also termed penetratin) [19],
the herpes virus protein VP22 that regulates transcription, theFig. 2. Schematic drawing of the ryanodine receptor (RyR). RyR is a calcium chan
produce calcium release from this internal calcium stock. MCa has a well identifie
Binding of MCa to its site on RyR triggers calcium release from endoplasmic reticulu
calcium indicator as shown here (for details see [7]). FKBP12: FK506 Binding Prochimeric peptide transportan [20] made in part by the
neuropeptide galanin and by the wasp venom peptide
mastoparan, and polyarginine peptides [21]. MCa has in
common with these peptides the following characteristics: 1)
it is a small peptide, 2) it is heavily charged, 3) it penetrates
efficiently in all cell types and in 100% of the treated cells, 4)
its penetration is fast and doesn't require cell energy
suggesting that it can penetrate without an endocytosis-type
mechanism, 5) its penetration doesn't apparently require the
presence of cell surface receptors, and 6) MCa can carry high
molecular weight cargoes during the penetration process. The
CPPs have proven invaluable for the efficient cell penetration
of oligonucleotides [22], plasmids [23], antisense peptide
nucleic acids [24], peptides [25], proteins [26,27], liposomes
[28] and nanoparticles [29]. CPPs open the door to important
new applications: antisense strategies for pain treatment [24],
novel probes for intracellular magnetic labeling both in vitro
and in vivo [30], brain delivery of antineoplastic agents [31]
or other therapeutic biomolecules [32], delivery of cyclos-
porine A for inhibition of cutaneous inflammation [33], etc.
Because MCa appears to represent the first known natural
disulfide-bridged cell penetrating peptide that possesses a well
identified intracellular target, we further characterized its
properties of cell penetration. We investigated the concentra-
tion dependence of MCa penetration, its cell toxicity and its
mechanism of penetration. For the latter, we studied i) the
effect of transmembrane potential variation onto the penetra-
tion and ii) the affinity of MCa for various membrane lipids.
The data obtained further strengthen the hypothesis that MCa
reaches its pharmacological target by entering cells through a
translocation mechanism. The lack of cell toxicity of this
peptide vector, combined with the availability of pharmaco-
logically inactive analogues, suggest that MCa derivatives
will permit future promising technological and medical
applications.nel localized in the membrane of the endoplasmic reticulum. Its function is to
d binding site on RyR that is localized on the cytoplasmic side of the channel.
m vesicles and that can be measured by the change in fluorescence intensity of a
tein 12 kDa.
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2.1. Materials
The disialoganglioside NeuAcα2–8NeuAcα2–3Galβ1–4Glcβ1–Cer
(GD3) and dipalmitoylphosphatidylcholine (DPPC) were purchased from
Matreya Inc and Sigma, respectively.
2.2. MCa and MCab peptide synthesis
The chemical syntheses of MCa and its biotinylated derivative MCab were
performed as previously described [2,17].
2.3. Cell culture
HEK293 (human embryonic kidney cells, ATCC) were maintained at 37 °C
in 5% CO2 in DMEM (Dulbecco's modified Eagle's medium, InVitrogen)
supplemented with 10% (v/v) heat-inactivated foetal bovine serum (InVitrogen)
and 10.000 units/ml streptomycine and penicillin (InVitrogen).
2.4. Formation of the MCab–Streptavidin–Cyanine3/5 complex
Soluble streptavidin–cyanine 5 or streptavidin–cyanine 3 (Strep–Cy5 or
Strep–Cy3, Amersham Biosciences) was mixed with four molar equivalents
of MCab for 2 h at 37 °C in the dark, in phosphate-buffered saline (PBS, in
mM: NaCl 136, Na2HPO4 4.3, KH2PO4 1.47, KCl 2.6, CaCl2 1, MgCl2 0.5,
pH 7.2).
2.5. Flow cytometry
After 1 h incubation with MCab–Strep–Cy5 complexes, the cells were
washed twice with PBS to remove extracellular complexes, and, where
indicated, treated with 1 mg/ml trypsin (InVitrogen) for 10 min at 37 °C to
remove cell surface-bound complexes. After trypsin incubation, the cell
suspension was centrifuged at 500 g and cells were resuspended in PBS
containing 1 μg/ml of propidium iodide (Sigma). For experiments that did
not include a step with propidium iodide (dose–response data), the MCab–
Strep–Cy3 complex was used instead of MCab–Strep–Cy5.
For experiments with heparin-treatment, complexes were prepared in PBS
containing 10 μg/ml of heparin (heparin sodium from bovine intestinal, Sigma).
The complexes were then incubated with cells. Cells were rinsed twice with the
PBS solution that contains heparin before and after incubation with the MCa
complexes.
For experiments in which the KCl concentration gradient was altered to
induce cell depolarization, the MCa complexes were prepared in solutions with
variable NaCl/KCl ratios (composition in mM: NaCl 145 to 5, KCl 5 to 145,
CaCl2 2.5, MgCl2 1.2, Glucose 10, HEPES 10, pH 7.4). Before and after
incubation with MCa complexes, cells were rinsed twice with these different
solutions.
Flow cytometry analyses, under all these different experimental condi-
tions, were performed with live cells using a Becton Dickinson FACSCalibur
flow cytometer (BD Biosciences). Data were obtained and analyzed using
CellQuest software (BD Biosciences). Live cells were gated by forward/side
scattering from a total of 10.000 events.
2.6. MTT assay
HEK293 cells were seeded into 96 well micro plates at a density of
approximately 5000 cells/well. Then the cells were incubated in suspension with
different concentrations of MCa up to a maximum of 10 μMat 37 °C for a period
of 4 or 24 h. In addition to MCa, control wells with or without cells in cell culture
medium were included for each experiment. All assays were run in triplicates.
The cell viability was measured using the Cell Quanti-MTT assay Kit (Bioassay,
USA). Here, the conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium
bromide (MTT) into purple colored MTT formazan by the living cells indicates the
extent of cell viability. The optical density was measured at 570 nm using the
FLUOstar OPTIMA microplate reader (BMG Labtech) followed by analyses.2.7. Immunocytochemistry
For analysis of the subcellular localization of the MCab–Strep–Cy3
complexes, following complexes application, cells were fixed 10 min in 4%
paraformaldehyde, rinsed in PBS and incubated for 1 h with FITC-conjugated
Concanavalin A (Molecular Probes, 5 μg/ml) to stain the membrane and with
TO-PRO-3 iodide (Molecular Probes, 1 μM) to stain the nucleus. For staining of
cytoskeleton, cells were fixed and permeabilized with cold methanol for 10 min,
rinsed twice in PBS and incubated for 2 h with a mouse anti-α-tubulin antibody
(1:1000, Sigma). After two washes in PBS, cells were incubated for 1 h with
Alexa 488-conjugated-anti-mouse IgG antibody (1:1000, Molecular Probes).
Cells were then mounted in Vectashield mounting medium (Vector laboratories).
Preparations were analyzed by confocal laser scanning microscopy using a Leica
TCS-SP2 operating system. Alexa-488 and Cy3 or propidium iodide
fluorescences were sequentially excited and collected. Images were merged in
Adobe Photoshop 7.0.
2.8. Surface pressure measurements
The surface pressure was measured with a fully automated microtensiometer
(μTROUGH SX, Kibron Inc.). The apparatus allowed the recording of the
kinetics of interaction of a ligand with a monomolecular film using a set of
specially designed Teflon troughs. All experiments were carried out in a
controlled atmosphere at 20±1 °C. Monomolecular films of the indicated lipids
were spread on ultra-pure water subphases (volume of 800 μl) from hexane:
chloroform:ethanol (11:5:4, v/v/v) as described previously [34]. After spreading
of the film, a minimal lapse time of 5 min was awaited to allow solvent
evaporation. To measure the interaction of MCa with lipid monolayers, various
concentrations of the peptide were injected in the subphase with a 10 μl
Hamilton syringe, and the resulting pressure increases produced by peptide
incorporation were recorded until reaching the equilibrium (maximal surface
pressure increase usually obtained after 100–150 min of interaction). For the
dose-dependent interaction between MCa and GD3, the monomolecular films of
GD3 were prepared at an initial surface pressure (πi) of 10 mN m
−1. The data
were analyzed with the Filmware 2.5 program (Kibron Inc.). The accuracy of the
system for surface pressure measurements was 0.25 mN m−1 under our
experimental conditions.3. Results
3.1. Cell distribution of MCab–Strep–Cy5 and time-dependent
re-distribution towards the nucleus
In a former study, we have demonstrated that MCab–Strep–
Cy3 complexes enter efficiently in the cytoplasm of various
living cell types [17]. Cell entry was not prevented by inhibitors
of endocytosis or pinocytosis or by incubation at 4 °C. Cell
fixation also did not appear to alter the cellular distribution of
the complex even though it appears more questionable for other
CPPs [35]. Here, we further investigated by confocal micros-
copy the cell distribution of MCab–Strep–Cy5 in HEK293 cells
after 1 h incubation of the cells with 333 nM of the complex
(Fig. 3). Surface labeling of HEK293 cells was performed with
concanavalin A whereas the nuclei of cells were labeled with
propidium iodide (Fig. 3A). Comparison of these labeling with
that of MCab–Strep–Cy5 clearly illustrate the presence of the
latter at both the plasma membrane and inside the cytoplasm of
cells. The staining of the complex appeared somewhat
punctuate in a confocal plane. Preliminary data seem to suggest
that this punctuate distribution appears related to the presence of
streptavidine. This protein may possibly non specifically
associate to endogenous cell proteins. This question will need
Fig. 3. Subcellular localization of MCab–Strep–Cy5 complexes studied by confocal immunofluorescence microscopy and compared to the localization of
concanavalin A (A), α-tubulin (B), and as a function of time (C). (A) Subcellular localization of MCab–Strep–Cy5 complex (blue) in HEK293 cells compared to a
marker of the plasma membrane. Cells were incubated 1 h with 333 nM of MCab–Strep–Cy5. The plasma membrane is stained with concanavalin A (green) and the
nuclei with propidium iodide (red). Images are from a single confocal plane. (B) As in panel A but for a comparison with a cytoskeleton marker (anti α-tubulin
antibody, green). (C) Modifications in cell distribution of MCab–Strep–Cy3 complexes after cell translocation. Confocal Cy3 (red, MCab–Strep–Cy3 complexes) and
To-PRO (blue, nuclei) fluorescence images of HEK293 cells incubated with 333 nM complexes for 2 h (left panel), 4 h (middle panel) and 24 h (right panel). Note the
progressive labeling of the nuclei by the MCab–Strep–Cy3 complexes.
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the distribution of MCab–Strep–Cy5 with that of α-tubulin, a
marker of the cytoskeleton. A clear lack of colocalization is
evidenced (Fig. 3B) between this cytoskeleton marker and
MCab–Strep–Cy5 complex. The diffuse staining of α-tubulin
was linked to the use of HEK293 cells since a similar staining
was observed in the absence of MCa and also with different
commercial antibodies (data not shown). We next followed the
evolution as a function of time of the cellular distribution of the
MCab–Strep–Cy3 complex (Fig. 3C). After 2 h of incubation,
the complex was mostly present in the cytoplasm. Between 4
and 24 h of incubation, it was mostly perinuclear and
colocalized with the nucleus. The regular target of MCa is
RyR, and the site of binding of MCa on RyR is strictly localized
in the cytoplasm. The localization of the MCab–Strep–Cy3 inthe nucleus cannot result from its binding onto RyR. Using a
specific pull-down assay with Strep-polystyrene beads and
MCab as a bait for interaction with cDNA, we evidenced that
MCab does not interact with cDNA (data not shown). Thus, the
presence of MCab–Strep–Cy3 complex in the nucleus does not
seem to arise from an interaction with DNA.
3.2. Study of the cell penetration and cell toxicity of
MCab–Strep–Cy5 by FACS
FACS is an interesting method to work out the quantitative
aspects of MCab–Strep–Cy5 penetration on live cells. Howev-
er, FACS analysis does not allow distinguishing between cell
surface bound fluorescence and intracellular fluorescence. Cell
surface fluorescence is expected to arise from MCab–Strep–
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membrane, through electrostatic interactions with either lipids,
or specific protein receptors or proteoglycans. In order to
destroy the MCab–Strep–Cy5 complex present on the external
face of the membrane and to measure only the fluorescent signal
corresponding to the penetrated complex, cells were treated
with trypsin before FACS analysis. Interactions of different
CCPs, such as Tat, with proteoglycans have been described
previously [36]. We then investigated the effect of pre-
incubating MCab–Strep–Cy5 with heparin on the cell penetra-
tion of the fluorescent complex. Heparin is one of the major
glycosaminoglycans that form the polysaccharide chain of the
proteoglycans and therefore should competitively displace the
interactions of the MCab–Strep–Cy5 with proteoglycans.
However, binding of heparin on MCa may also non-specifically
hinder the translocation of the MCab–Strep–Cy5 complex by
neutralizing the positive charges provided by the basic residues
of MCa. Fig. 4A (left panel) shows that the incubation of
MCab–Strep–Cy5 with 10 μg/ml heparin before and during cell
incubation significantly decreased the cell fluorescence. The
mean fluorescence value was decreased from a value of 307
(arbitrary units) in the absence of heparin to a value of 78.Fig. 4. Effects of heparin and/or trypsin treatment on MCab–Strep–Cy5 cell penetr
Incubation of HEK293 cells and of the MCab–Strep–Cy5 complex with 10 μg/ml hep
is 307 without treatment, whereas with heparin treatment, it drops down to 78. Treatm
treatment with 1 mg/ml trypsin further decreases the mean fluorescence value down
reaches a mean value of 3.1 and is not influenced by trypsin or heparin treatment (not s
(B) Cell toxicity of 1 μM of Strep–Cy5 and of the MCab–Strep–Cy5 complex as asse
indicated in percentages. (C) Cell toxicity of MCa as assessed by the MTT test. HEK2
MCa.Further treatment of the cells with 1 mg/ml trypsin to remove
the surface bound MCab–Strep–Cy5 associated fluorescence
had only a minor effect by further decreasing the mean
fluorescence value to 64 (Fig. 4A, right panel). These data
indicate that heparin can significantly decrease MCa uptake
by cells either by hindering its interaction with proteoglycans
or by altering its properties of interaction with negatively
charged lipids by binding to its basic face. However a sig-
nificant part of the MCab–Strep–Cy5 is still internalized in
the presence of heparin. The data also show that surface
associated MCab–Strep–Cy5 complexes are of limited quan-
tities compared to intracellular complexes. Nevertheless, since
it is clear that FACS analysis can be validly used for studying
cellular uptake of CPPs only when a protease digestion step is
included, (see also [35]), we thus performed all the subsequent
analyses by including a trypsin digestion before FACS
measurements.
We next determined whether 1 h incubation with MCab alone
or MCab–Strep–Cy5 could be toxic for HEK293 cells by
measuring the incorporation of propidium iodide on the total
cell population (Fig. 4B). The incorporation of propidium
iodide that witnesses cell death was compared to the oneation (A) and cell toxicity of the complexes (B, C) as assessed by FACS. (A)
arin reduces cell penetration of the complex (left panel). Mean Cy5 fluorescence
ent of cells and MCab–Strep–Cy5 with 10 μg/ml heparin combined with a cell
to 64. Control fluorescence following treatment of cells with Strep–Cy5 alone
hown). MCab–Strep–Cy5 cell penetration was tested at a concentration of 1 μM.
ssed by iodide propidium cell incorporation. Iodide propidium positive cells are
93 cells were incubated for 4 or 24 h in the presence of variable concentrations of
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were found between Strep–Cy5 and MCab–Strep–Cy5 for
concentrations up to 1 μM. The example shown in Fig. 4B is the
most unfavorable case that we observed with most other cases
ranging between 3 and 7% propidium iodide positive cells. For
MCab–Strep–Cy5 concentrations higher than 1 μM, cell
toxicity was observed but it was related to the presence of
Strep–Cy5, since this effect was not observed when high
concentrations of MCab alone (higher than 1 μM) were used
(data not shown). The absence of MCa toxicity on HEK293
cells validates the use of this cell model for the study of
internalization of MCa. However, this lack of toxicity may be
related to the low expression of RyR1 in this cell line and needs
to be controlled in different cell type.
Since for periods of incubation longer than 1 h, MCa could
be detected also in the nucleus, there is a possibility that cell
toxicity may be a late phenomenon. We therefore also examined
whether cells were sensitive to a prolonged exposure to MCa
(4 h and 24 h incubation periods). MCa was tested alone since
potential toxic effects of streptavidine were without cellular
interest. HEK293 cell viability was measured using the CellFig. 5. Dose-dependent cell penetration of MCab–Strep–Cy3 complex (A–C). (A)
indicated concentration. Cells underwent a trypsin treatment at 1 mg/ml before FA
concentration. Data were fitted with the following equation y= y0+a× (1−
immunofluorescence images of HEK293 cells incubated for 1 h with different c
To-PRO-3 (blue).Quanti-MTT assay Kit from Bioassay corporation. As shown in
Fig. 4C, there was absolutely no sign of significant cell toxicity
for MCa concentrations up to 5 μMwhether the incubation time
lasted 4 h or 24 h Only 8.0±1.4% cell toxicity was detected
for an MCa concentration of 10 μM and a 24-h incubation
time.
3.3. Dose-dependent penetration of MCab–Strep–Cy3 in
HEK293 cells
Since MCab appears to act as an efficient CPP, we next
determined the dose-dependence of cell penetration of the
MCab–Strep–Cy3 complex. A mechanism of penetration that
would rely on endocytosis would be expected to saturate,
whereas a mechanism based on membrane translocation should
be less prone to saturation. Fig. 5A illustrates that a detectable
cell penetration is visible at a concentration as low as 10 nM,
and that this penetration increases without any sign of saturation
with increasing complex concentrations (Fig. 5B). The rather
uniform increase in fluorescence values argues against the
notion of two parallel mechanisms of penetration with widelyFACS analysis of the cell penetration of the MCab–Strep–Cy3 complex at the
CS analysis. (B) Mean cell fluorescence as a function of MCab–Strep–Cy3
exp(−b×x)) where y0=−3.8, a=199 and b=1.5×10−3. (C) Confocal
oncentrations of MCab–Strep–Cy3 complexes (red). Nuclei are stained with
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penetration of the complex can occur for a wide range of
concentration without any alteration in the cell distribution of
the penetrated complex (Fig. 5C).
3.4. Voltage-dependence of MCab–Strep–Cy3 penetration in
HEK293 cells
Penetration of the MCab–Strep–Cy3 complex through a
membrane translocation process can be driven by two
processes. First, the concentration gradient of the complex
will drive the complex into the cell and act to equilibrate the
external and internal concentrations. Second, MCa has a net
global charge that is greatly positive and thus a negativeFig. 6. Effect of increasing extracellular K+ concentrations on MCab–Strep–Cy3
concentrations on MCab–Strep–Cy3 cell penetration. Right panels illustrate control
with Strep–Cy3) at 145 mMKCl. The KCl gradient had no effect on control values (n
value of 145), 125 mM (middle, mean cell fluorescence value of 40) and 145 mM KC
mean cell fluorescence as a function of KCl concentration. Linear regression of
descending slope a=−0.72.membrane potential should favor MCa penetration. This second
possibility was tested by altering the membrane potential of
HEK293 cells by increasing external KCl concentrations.
External NaCl concentrations were correspondingly reduced
in order to preserve the solution osmolarity. Fig. 6A illustrates
that increasing KCl concentrations produces a clear reduction in
cell entry of the MCab–Strep–Cy3 complex. This reduction in
cell entry was followed by plotting the mean cell fluorescence
observed by FACS as a function of KCl concentration (Fig. 6B).
The data indicate that there is a linear decrease in fluorescence
intensity upon membrane depolarization demonstrating that
membrane potential is involved in attracting MCa into the cells.
However, at 145 mM KCl, a concentration where presumably
all cells would be depolarized to 0 mV, we still observe a smallcell penetration (A, B). (A) FACS analyses of the effects of increasing KCl
experiments (cell fluorescence without any complex, top, and cell fluorescence
ot shown). Left panels illustrate the effects of 5 mM (top, mean cell fluorescence
l (bottom, mean cell fluorescence value of 17), respectively. (B) Evolution of the
the data with y=y0+a×x with the maximum fluorescence y0=139.5 and the
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of the concentration gradient.
3.5. MCa interaction with membrane lipids
To assess whether MCa could interact with specific
membrane lipids, monomolecular films of DPPC and gangli-
oside GD3 were spread at the air–water interface. MCa was
then added in the aqueous subphase at a concentration of
1 μM. The variations in the surface pressure of the film were
then continuously recorded as a function of time (Fig. 7A).
The data show that MCa is able to penetrate into the
monolayer of GD3, as objectified by the large increase in
surface pressure of the GD3 film. In contrast, MCa does not
induce significant change in the surface pressure of the DPPC
film, indicating that MCa does not recognize this glyceropho-Fig. 7. Interaction of MCa with membrane lipids (A, B). (A) Surface pressure
measurement with monomolecular films of GD3 or DPPC. Kinetics of changes
in surface pressure induced by the application of 1 μMMCa. The data illustrate
the interaction of MCa with GD3 but not DPPC. The initial surface pressure was
approximately 10 mN m−1. The data were fitted with an exponential rise to max
equation y=y0+a×(1−exp(−b×x)) where the initial surface pressure of the film
is y0=11.6 mN m
−1, the maximal increase in surface pressure a=22.9 mN m−1
and the time constant of surface pressure change b= 3×10− 4 s−1. (B) Evolution
of surface pressure of GD3 lipid films as a function of MCa concentration. Data
were fitted with a sigmoid function y=a/(1+exp(−(x−x0)/b)) where the
maximum surface pressure increase a=22.1 mN m−1, the slope b=0.006 and
the half-maximal effect occurs at a concentration of x0=0.49 μM.spholipid. A dose-dependent interaction of MCa with lipid
monolayers formed with ganglioside GD3 is shown in
Fig. 7B. The interaction is clearly detectable at a concentra-
tion of 100 nM of MCa and reaches a maximum at 750 nM.
The half-maximal effect was obtained at a concentration of
490 nM.
4. Discussion
4.1. The value of MCa for cell penetration of proteins
MCa appears as an interesting new candidate to serve
as vector to mediate cell penetration of compounds that
are otherwise unable to cross the plasma membrane.
Because of the localization of its natural pharmacological
site, it leaves little doubt that it reaches the cytoplasm of
cells. A pharmacological profiling of MCa has begun [7],
and several point mutated analogues devoid of activity on
RyR and Ca2+ homeostasis are already available. Along
with the present observation that MCa is not toxic to
HEK293 cells likely due to the poor expression of RyR in
these cells, we expect that MCa analogues selected for
their inability to bind RyR will be extremely useful as
peptide vector for the cell penetration of compounds of
interest. Consistent with a mechanism of cell penetration
that does not require the presence of extracellular
receptors, RyR-defective mutants of MCa proved to
efficiently penetrate into cells (data not shown). Along
with the observation that CPPs possess no clear sequence
homology between each other, these data predict a great
level of flexibility for the design of numerous MCa cell
penetrating analogues. Nevertheless, the molecule in its
actual configuration is not devoid of interesting features
since: (1) a wide range of concentration can be exploited
(as low as 10 nM for 1 h incubation), (2) it induces entry
of Strep, a protein as large as 60 kDa, (3) the cargo
attains the cytoplasm as well as the nucleus which further
widens the possible range of applications, and (4) it can
enter many different cell types [17]. MCa not only favors
the penetration of proteins, it also allows the penetration
of 10–15 nm quantum dots coated with 5–7 Strep
molecules each (unpublished data). This finding suggests
that MCa will have many applications for in vivo cell
tracking or other cell imaging techniques.
4.2. Interaction of MCa with lipids
Surface pressure measurements of MCa with monomo-
lecular films of specific membrane lipids indicate that MCa
can interact with gangliosides such as GD3, whereas it
totally ignores DPPC. Therefore, these data suggest that the
site of interaction of MCa with the external leaflet of plasma
membranes may correspond to discrete areas enriched in
negatively charged lipids such as gangliosides. Correspond-
ingly, the lack of interaction of MCa with DPPC is
consistent with the presence of a positive charge in the
polar head group of this lipid, a property that should not be
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contrast, the positively charged peptide is expected to
interact with negatively charged lipids. In the external leaflet
of the plasma membrane, gangliosides are the most abundant
lipids belonging to this category. Altogether, these data
suggest that the initial interaction of MCa with plasma
membranes occurs in gangliosides enriched domains. These
domains may correspond to specific lipid rafts as previously
suggested [37]. The only other candidate lipid that may
possibly interact with MCa, phosphatidylserine, that is also
negatively charged, is mainly located at the cytoplasmic side
of the membrane. An interaction of MCa with lipids does
not provide a mechanism for the translocation of MCa across
the plasma membrane. However, we may tentatively
speculate that MCa/GD3 interactions neutralize the basic
surface of MCa and favor the interaction of the hydrophobic
face with the inner part of the membrane. Eventually, GD3
may translocate transiently from the outer part of the
membrane towards the inner part in order to deliver MCa
that may then prefer to establish new electrostatic interac-
tions with novel, locally based, negatively charged lipids or
proteins because of a richer environment in negative charges.
4.3. Endocytosis versus cell translocation
The question of the mechanism of cell penetration of CPPs
appears to be hotly debated. Arguments have been put forward
in favor of endocytosis, as well as for a pure energy inde-
pendent membrane translocation mechanism. It is worth
emphasizing that there is no contradiction for the coexistence
of an endocytic pathway and a nonendocytic one. We discuss
both issues.
Cell penetration of Tat has been demonstrated in experi-
mental conditions in which cellular energy was depleted,
temperature lowered, clathrin-dependent endocytosis inhibited,
and cholesterol removed [38]. Arguments in favor of cell
translocation of MCa are the observations that penetration also
occurs at 4 °C and upon treatment of cells with amiloride and
nystatin [17]. The fact that the penetration of MCa does not
saturate with increasing concentrations cannot be presented as
an argument for a translocation mechanism since a non
saturable step such as lipid interaction may be followed by
endocytosis. Nevertheless, we provide two additional evidences
in this manuscript for the non-endocytotic pathway. First, MCa
cell entry is sensitive to membrane potential variation in manner
coherent with the global net positive charge of MCa. To our
knowledge, endocytosis is not known to be inhibited by voltage
reduction. Second, MCa interacts with negatively charged
membrane lipids, a condition that is required for any type of
mechanism of translocation. Specificity of this interaction is
demonstrated by the lack of association to a non-charged lipid.
Interaction with negatively charged lipids was also observed for
Antp [39]. The observation that cell fixation may influence the
cell distribution of CPP renders the nonendocytic pathway
difficult to defend [35]. However, this artifact of procedure may
presumably be valid only for CPPs that are not conjugated to
cargoes. In the present work, MCab was coupled to Strep, aquite large cargo of about 60 kDa, before cell entry. This is an
important difference with several other studies in which the
fluorescent complex is only formed after cell entry, fixation and
permeabilization. The present data also show that cell
penetration can still be evidenced by FACS despite a treatment
with trypsin. In fact, only a tiny fraction of MCab–Strep–Cy3
remains associated to the extracellular face of the membrane
when heparin is added since trypsin treatment produces only a
minimal reduction on cell penetration. In addition, the
observation that there is a clear time-dependent evolution of
the cell distribution of the MCab–Strep–Cy3 complex warrants
against an artifact of cell fixation. The presence of the complex
in the nucleus after a period of 24 h is a strong indication that the
peptide must be present in a free-form in the cytoplasm after a
specific period. Finally, we have not noticed any evident
difference between experiments with live [17] and fixed cells. It
should be emphasized that the most compelling argument in
favor of cell translocation is the fact that MCa's pharmacolog-
ical target has a strict cytoplasmic localization [15]. Also, the
fast kinetics of MCa effects on calcium homeostasis is
indicative that it reaches its binding site extremely rapidly,
through a process that is largely incompatible with endocytosis
[7]. In that respect, the coupling to a fluorescent Strep largely
slows down the kinetic of cell entry. Electron microscopy
studies with CPPs coupled to nanoparticles that are too large to
undergo endocytosis will likely bring further evidence in favor
of membrane translocation.
The observation that heparin treatment significantly inhibits
MCa penetration into HEK293 cells may be in favor of an
endocytic pathway. This may suggest that part of MCa cell
penetration involves binding onto proteoglycans. We presume
that it is the basic character of MCa that promotes its binding to
negatively charged complex sulfated glycosaminoglycans of the
cell surface. Although heparin may indeed competitively hinder
MCa binding onto HPSG, and hence endocytosis, it may also
non-competitively neutralize the basic face of MCa and partially
block the interaction with negatively charged lipids and cell
translocation. This issue will be resolved by examining cell
penetration of MCa in proteoglycan-deficient cell lines.
Nevertheless, we cannot rule out that a significant fraction of
MCa entry also occurs via lipid raft-dependent macropinocy-
tosis, a specialized form of fluid phase endocytosis, that is
independent of caveloe, chlathrin and dynamin [40].
4.4. Role of membrane potential
What drives the penetration of MCa into cells? There are
two potential driving forces that can be evoked. Similarly to
the cell penetration of ions through channels, MCa may rely
on its concentration gradient that may be progressively
neutralized during passive diffusion into the cell. In addition,
since it possesses a net global charge of +8, it may also
penetrate because of the negative potential of cells. This is
indeed what we observed since the net amount of MCab–
Strep–Cy3 entry was lessened by membrane depolarization.
As such, negative membrane potentials will act as “concen-
trators” of MCa into the cell, which may well explain why the
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was higher inside the cell than outside upon equilibrium [17].
Similarly, voltage-dependence of cell penetration has also
been observed for the Antennapedia-derived penetratin [41].
In the case of penetratin, a significant increase in the rate of
entry had been observed which is also expected. It will thus
be interesting to check whether MCa entry is also accelerated
by voltage.
4.5. Interesting parallels between MCa and peptide A and
relevance to excitation-contraction coupling
The limited sequence homology between MCa and
peptide A, combined with the observation that both peptides
bind onto the same site of RyR [15] allow three interesting
questionings. First, the observation that MCa cell entry is
sensitive to the voltage gradient is particularly intriguing.
The complex of channels that links the DHPR with RyR is
highly sensitive to voltage changes. A modification in
membrane potential is sensed by the DHPR and transduced
to RyR to induce SR Ca2+ release. However, little is known
about the identity of the DHPR sequence that is responsible
for this voltage-sensitive transduction step. The domain A is
an important determinant for the coupling between DHPR
and RyR. It will therefore be of interest to investigate
whether domain A presents some kind of voltage-dependence
in its coupling to RyR. Second, the observation that MCa
interacts with a negatively charged lipid, similarly raises the
question on peptide A interaction with lipids and on the
possible role of such an interaction on excitation–contraction
coupling. Third, MCa appears to efficiently cross the plasma
membrane. Peptide A is also positively charged and the
question of a partial membrane penetration of this sequence
that has a predicted cytoplasmic localization is thus also
opened.
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